{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T08:38:26Z","timestamp":1771490306739,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.psychres.2019.04.013","type":"journal-article","created":{"date-parts":[[2019,4,11]],"date-time":"2019-04-11T18:52:46Z","timestamp":1555008766000},"page":"203-209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Prevalence and predictors of psychotropic medication use in adolescents and adults with autism spectrum disorder in Italy: A cross-sectional study"],"prefix":"10.1016","volume":"276","author":[{"given":"Laura","family":"Fusar-Poli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natascia","family":"Brondino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Rocchetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrice","family":"Petrosino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Arillotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Damiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umberto","family":"Provenzani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmelo","family":"Petrosino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenio","family":"Aguglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierluigi","family":"Politi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2019.04.013_bib0001","series-title":"U.S. Dept. of Health and Human Services, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health","article-title":"Assessing psychopathology and behavior problems in persons with mental retardation: a review of available instruments","author":"Aman","year":"1991"},{"key":"10.1016\/j.psychres.2019.04.013_bib0002","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association, 2013. Diagnostic and Statistical Manual of Mental Disorders (DSM-5\u00ae). American Psychiatric Pub.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"10.1016\/j.psychres.2019.04.013_bib0003","article-title":"Prevalence of autism spectrum disorder among children aged 8 years\u2014autism and developmental disabilities monitoring network, 11 sites, United States, 2014","author":"Baio","year":"2018","journal-title":"MMWR"},{"key":"10.1016\/j.psychres.2019.04.013_bib0004","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1108\/AMHID-10-2015-0049","article-title":"Update on psychopharmacology for autism spectrum disorders","volume":"10","author":"Bertelli","year":"2016","journal-title":"Adv. Ment. Health. Intellect. Disabil."},{"key":"10.1016\/j.psychres.2019.04.013_bib0005","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/1362361307078132","article-title":"Systematic review of the effectiveness of pharmacological treatments for adolescents and adults with autism spectrum disorder","volume":"11","author":"Broadstock","year":"2007","journal-title":"Autism"},{"issue":"1","key":"10.1016\/j.psychres.2019.04.013_bib0006","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1477-7525-10-47","article-title":"Comparison of the burden of illness for adults with ADHD across seven countries: a qualitative study","volume":"10","author":"Brod","year":"2012","journal-title":"Health Qual. Life Outcomes"},{"key":"10.1016\/j.psychres.2019.04.013_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/258589","article-title":"Complementary and alternative therapies for autism spectrum disorder","author":"Brondino","year":"2015","journal-title":"Evid. Based. Complement. Alternat. Med."},{"key":"10.1016\/j.psychres.2019.04.013_bib0008","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s10803-015-2619-y","article-title":"Pharmacological modulation of GABA function in autism spectrum disorders: a systematic review of human studies","volume":"46","author":"Brondino","year":"2016","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.psychres.2019.04.013_bib0009","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1001\/archgenpsychiatry.2011.38","article-title":"Epidemiology of autism spectrum disorders in adults in the community in England","volume":"68","author":"Brugha","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psychres.2019.04.013_bib0010","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1007\/s10803-014-2170-2","article-title":"Psychiatric comorbidity and medication use in adults with autism spectrum disorder","volume":"44","author":"Buck","year":"2014","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.psychres.2019.04.013_bib0011","first-page":"25","article-title":"Treatment of depression: antidepressant monotherapy and combination therapy","volume":"4","author":"Cascade","year":"2007","journal-title":"Psychiatry"},{"key":"10.1016\/j.psychres.2019.04.013_bib0012","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/aur.1922","article-title":"Measurement properties of tools used to assess depression in adults with and without autism spectrum conditions: a systematic review","volume":"11","author":"Cassidy","year":"2018","journal-title":"Autism Res."},{"key":"10.1016\/j.psychres.2019.04.013_bib0013","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.rasd.2014.05.003","article-title":"Factors associated with quality of life in individuals with autism spectrum disorders: a review of literature","volume":"8","author":"Chiang","year":"2014","journal-title":"Res. Autism Spectr. Disord."},{"key":"10.1016\/j.psychres.2019.04.013_bib0014","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1542\/peds.2009-0958","article-title":"Randomized, controlled trial of an intervention for toddlers with autism: the Early Start Denver Model","volume":"125","author":"Dawson","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.psychres.2019.04.013_bib0015","series-title":"Adolescents and Adults with Autism Spectrum Disorders","first-page":"161","article-title":"Pharmacotherapy of behavioral symptoms and psychiatric comorbidities in adolescents and adults with autism spectrum disorders","author":"Doyle","year":"2014"},{"key":"10.1016\/j.psychres.2019.04.013_bib0016","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s10803-009-0750-3","article-title":"A longitudinal investigation of psychotropic and non-psychotropic medication use among adolescents and adults with autism spectrum disorders","volume":"39","author":"Esbensen","year":"2009","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.psychres.2019.04.013_bib0017","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10803-008-0599-x","article-title":"Age-related differences in restricted repetitive behaviors in autism spectrum disorders","volume":"39","author":"Esbensen","year":"2009","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.psychres.2019.04.013_bib0018","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s40265-013-0021-7","article-title":"Pharmacotherapy for the core symptoms in autistic disorder: current status of the research","volume":"73","author":"Farmer","year":"2013","journal-title":"Drugs"},{"key":"10.1016\/j.psychres.2019.04.013_bib0019","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ridd.2016.10.014","article-title":"Long-term outcome of a cohort of adults with autism and intellectual disability: a pilot prospective study","volume":"60","author":"Fusar-Poli","year":"2017","journal-title":"Res. Dev. Disabil."},{"key":"10.1016\/j.psychres.2019.04.013_bib0020","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1007\/s10803-017-3258-2","article-title":"Diagnosing ASD in adults without ID: accuracy of the ADOS-2 and the ADI-R","volume":"47","author":"Fusar-Poli","year":"2017","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.psychres.2019.04.013_bib0021","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ridd.2004.05.003","article-title":"Repetitive behaviors in autism: relationships with associated clinical features","volume":"26","author":"Gabriels","year":"2005","journal-title":"Res. Dev. Disabil."},{"key":"10.1016\/j.psychres.2019.04.013_bib0022","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1177\/1362361316646559","article-title":"Use of complementary and alternative medicine in children and adolescents with autism spectrum disorder: a systematic review","volume":"21","author":"H\u00f6fer","year":"2017","journal-title":"Autism"},{"key":"10.1016\/j.psychres.2019.04.013_bib0023","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1176\/appi.ajp.2011.10050764","article-title":"A double-blind placebo-controlled trial of fluoxetine for repetitive behaviors and global severity in adult autism spectrum disorders","volume":"169","author":"Hollander","year":"2012","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2019.04.013_bib0024","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/0269881117741766","article-title":"Autism spectrum disorder: consensus guidelines on assessment, treatment and research from the British Association for Psychopharmacology","volume":"32","author":"Howes","year":"2017","journal-title":"J. Psychopharm."},{"issue":"6","key":"10.1016\/j.psychres.2019.04.013_bib0025","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s00213-013-3263-x","article-title":"Psychopharmacological prescriptions for people with autism spectrum disorder (ASD): a multinational study","volume":"231","author":"Hsia","year":"2014","journal-title":"Psychopharmacol."},{"key":"10.1016\/j.psychres.2019.04.013_bib0026","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008372.pub2","article-title":"Tricyclic antidepressants for autism spectrum disorders (ASD) in children and adolescents","author":"Hurwitz","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.psychres.2019.04.013_bib0027","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1023\/A:1010715619091","article-title":"Letters to the editor: suppressed GABAergic inhibition as a common factor in suspected etiologies of autism","volume":"31","author":"Hussman","year":"2001","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.psychres.2019.04.013_bib0028","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/acps.12644","article-title":"Use of psychotropic drugs in patients with autism spectrum disorders: a systematic review","volume":"135","author":"Jobski","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.psychres.2019.04.013_bib0029","first-page":"217","article-title":"Autistic disturbances of affective contact","volume":"2","author":"Kanner","year":"1943","journal-title":"Nervous Child"},{"key":"10.1016\/j.psychres.2019.04.013_bib0030","first-page":"004","article-title":"Aripiprazole in patients with autistic spectrum disorders: a review and case reports","volume":"1","author":"Kirino","year":"2012","journal-title":"Autism\u2013Open Access. S"},{"key":"10.1016\/j.psychres.2019.04.013_bib0031","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/08830738050200030601","article-title":"Screening electroencephalograms in autism spectrum disorders: evidence-based guideline","volume":"20","author":"Kagan-Kushnir","year":"2005","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.psychres.2019.04.013_bib0032","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S2215-0366(15)00277-1","article-title":"Identifying the lost generation of adults with autism spectrum conditions","volume":"2","author":"Lai","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.psychres.2019.04.013_bib0033","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(13)61539-1","article-title":"Autism","volume":"383","author":"Lai","year":"2014","journal-title":"The Lancet"},{"key":"10.1016\/j.psychres.2019.04.013_bib0034","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.rasd.2012.03.005","article-title":"Polypharmacy profiles and predictors among adults with autism spectrum disorders","volume":"6","author":"Lake","year":"2012","journal-title":"Res. Autism Spectr. Disord."},{"key":"10.1016\/j.psychres.2019.04.013_bib0035","first-page":"389","article-title":"Pharmacological therapies for autism spectrum disorder: a review","volume":"40","author":"LeClerc","year":"2015","journal-title":"P. T."},{"key":"10.1016\/j.psychres.2019.04.013_bib0036","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1007\/s10803-016-2722-8","article-title":"Psychiatric co-occurring symptoms and disorders in young, middle-aged, and older adults with autism spectrum disorder","volume":"46","author":"Lever","year":"2016","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.psychres.2019.04.013_bib0037","series-title":"Autism Diagnostic Observation Schedule","author":"Lord","year":"2012"},{"key":"10.1016\/j.psychres.2019.04.013_bib0038","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/BF02172145","article-title":"Autism diagnostic interview-revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders","volume":"24","author":"Lord","year":"1994","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.psychres.2019.04.013_bib0039","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev-publhealth-031816-044318","article-title":"The changing epidemiology of autism spectrum disorders","volume":"38","author":"Lyall","year":"2017","journal-title":"Annu. Rev. Public Health."},{"key":"10.1016\/j.psychres.2019.04.013_bib0040","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1177\/1362361313498518","article-title":"Psychotropic medication use among children with autism spectrum disorders within the Simons Simplex Collection: are core features of autism spectrum disorder related?","volume":"18","author":"Mire","year":"2014","journal-title":"Autism"},{"key":"10.1016\/j.psychres.2019.04.013_bib0041","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1001\/jamapsychiatry.2017.4685","article-title":"The emerging clinical neuroscience of autism spectrum disorder: a review","volume":"75","author":"Muhle","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.psychres.2019.04.013_bib0042","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s00213-013-3140-7","article-title":"Pharmacological treatments prescribed to people with autism spectrum disorder (ASD) in primary health care","volume":"231","author":"Murray","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.psychres.2019.04.013_bib0043","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jaac.2016.03.012","article-title":"Antipsychotic use trends in youth with autism spectrum disorder and\/or intellectual disability: a meta-analysis","volume":"55","author":"Park","year":"2016","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry."},{"key":"10.1016\/j.psychres.2019.04.013_bib0044","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.rasd.2010.03.011","article-title":"A meta-analytic study on the effectiveness of comprehensive ABA-based early intervention programs for children with autism spectrum disorders","volume":"5","author":"Peters-Scheffer","year":"2011","journal-title":"Res. Autism Spect. Disord."},{"key":"10.1016\/j.psychres.2019.04.013_bib0045","doi-asserted-by":"crossref","first-page":"e4082","DOI":"10.1136\/bmj.e4082","article-title":"Recognition, referral, diagnosis, and management of adults with autism: summary of NICE guidance","volume":"344","author":"Pilling","year":"2012","journal-title":"Br. Med. J."},{"key":"10.1016\/j.psychres.2019.04.013_bib0046","series-title":"Raven's Progressive Matrices","author":"Raven","year":"1938"},{"key":"10.1016\/j.psychres.2019.04.013_bib0047","series-title":"Leiter International Performance Scale","author":"Roid","year":"2013"},{"key":"10.1016\/j.psychres.2019.04.013_bib0048","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s10803-006-0307-7","article-title":"Change in autism symptoms and maladaptive behaviors in adolescents and adults with an autism spectrum disorder","volume":"37","author":"Shattuck","year":"2007","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.psychres.2019.04.013_bib0049","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1007\/s10803-006-0248-1","article-title":"Behaviour management problems as predictors of psychotropic medication and use of psychiatric services in adults with autism","volume":"37","author":"Tsakanikos","year":"2007","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.psychres.2019.04.013_bib0050","series-title":"WAIS-R Manual: Wechsler Adult Intelligence Scale-Revised","author":"Wechsler","year":"1981"},{"key":"10.1016\/j.psychres.2019.04.013_bib0051","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004677.pub3","article-title":"Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)","author":"Williams","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.psychres.2019.04.013_bib0052","first-page":"322","article-title":"Linea guida dell'Istituto Superiore di Sanit\u00e0 su \u201cIl trattamento dei disturbi dello spettro autistico nei bambini e negli adolescenti\u201d: limiti e implicazioni","volume":"18","author":"Zappella","year":"2012","journal-title":"J. Psychopathol."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016517811930318X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016517811930318X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T05:36:10Z","timestamp":1759037770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016517811930318X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":52,"alternative-id":["S016517811930318X"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2019.04.013","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and predictors of psychotropic medication use in adolescents and adults with autism spectrum disorder in Italy: A cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2019.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}